Navigation Links
Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
Date:5/10/2011

SAN DIEGO, May 10, 2011 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported financial results for the first quarter ended March 31, 2011, and reviewed recent developments.

"In collaboration with Eisai, we are making progress in executing activities to support the submission of our response to the FDA's complete response letter for our lorcaserin new drug application," stated Jack Lief, Arena's President and Chief Executive Officer. "We are also continuing to selectively advance our earlier-stage programs, and we look forward to announcing top-line results from our APD811 Phase 1 trial this quarter."

Research and development expenses continued to decline in the first quarter of 2011 to $15.9 million, compared to $18.3 million in the first quarter of 2010. This decrease is primarily attributable to the workforce reduction Arena initiated in January 2011 and ongoing cost-containment efforts. Arena recorded restructuring charges of $3.5 million related to the workforce reduction in the first quarter of 2011. General and administrative expenses in the first quarter of 2011 totaled $6.9 million, compared to $7.0 million in the first quarter of 2010.

Total interest and other expense increased to $14.7 million in the first quarter of 2011, compared to $6.1 million in the first quarter of 2010. This increase is primarily attributable to a non-cash loss on extinguishment of debt of $10.5 million in the first quarter of 2011 due to Arena's principal prepayments on its Deerfield loan of $20.0 million and $17.7 million in January 2011 and March 2011, respectively. Including the $10.5 million non-cash debt extinguishment charge and $3.5 million of restructuring charges, Arena's net loss allocable to common stockholders in the first quarter of 2011 was $42.2 million, or $0.35 per share, compared to $31.3 million, or $0.33 per share, in the first quarter
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
2. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
3. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
4. Arena Pharmaceuticals Expands GPR119 Patent Portfolio for Type 2 Diabetes
5. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Friday, March 11
6. Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer
7. Arena Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
8. Arena and Eisai Complete End-of-Review Meeting with FDA for Lorcaserin New Drug Application
9. Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA
10. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension
11. Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... July 11, 2014 Patient engagement has ... consequently, organizations are turning to an assortment of ... As part of this evolving approach to patient ... communicate and engage patients throughout their experiences with ... empowerment. By mapping the patient journey and employing ...
(Date:7/11/2014)... 11, 2014 Research and Markets  has ... Market 2014-2018" report to their offering. ... needle is a hollow needle commonly used with a ... to extract fluids from it. A hypodermic needle is ... substances that cannot be ingested. Hypodermic needles are broadly ...
(Date:7/11/2014)... July 11, 2014 Research and Markets ... the "Immunoprotein Diagnostic Testing Market - Forecasts ... CAGR of 6% and is expected to be ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... testing has been segmented according to immunoprotein types ...
Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2
... Aug. 8, 2011 Systech International®, the recognized global ... leading systems engineering, automation, and manufacturing optimization services company, ... for the pharmaceutical market in Puerto Rico.  VCG now ... Systech and their extensive customer-base in region. ...
... 2011 - Pharmasset, Inc. (Nasdaq: VRUS ) announces ... to be held August 10 to 11, 2011 at the ... Executive Officer, will provide an overview of the company at ... 9:30 AM (ET). To access a simultaneous webcast ...
Cached Medicine Technology:Systech Selects Vantage Consulting Group as their Sales Agent in Puerto Rico 2Systech Selects Vantage Consulting Group as their Sales Agent in Puerto Rico 3Pharmasset to Present at Canaccord Genuity Growth Conference 2Pharmasset to Present at Canaccord Genuity Growth Conference 3
(Date:7/13/2014)... 2014 The federal court overseeing thousands ... filed against Johnson & Johnson’s Ethicon, Inc. is preparing ... expected to get underway next month. According to an ... Court, Southern District of West Virginia on July 9, ... 7, 2014 at 3:00 p.m. July selection is slated ...
(Date:7/13/2014)... Max International has recently ... be the featured guest at its Charity Exhibition and ... Attendees will learn about Max’s health products and ... basketball games and perform in a 3 point shoot-out. ... and energy-boosting supplements , has recently announced former NBA ...
(Date:7/13/2014)... 2014 Fadhits.com is popular among worldwide ... are extremely beautiful. Recently, the company has announced its ... 2014. What’s more, all these outfits are available at ... , Additionally, the supplier is now offering similar discounts ... dresses, it has many other designs for sale, including ...
(Date:7/13/2014)... imaging device developed at Cedars-Sinai can provide early ... brain and are a classic sign of Alzheimer,s ... a clinical trial in Australia. , The researchers ... oral presentation at the Alzheimer,s Association International Conference ... by conference organizers to participate in a "breaking ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 According to the ... is a step by step guide on what to do ... easily and quickly. Vkool writes in its review that readers ... to eat to revitalize their kidney health. Vkool also informs ... help people reverse their damaged kidney functions naturally. The book ...
Breaking Medicine News(10 mins):Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 3Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 4Health News:Fadhits.com Announces a Special Offer on Elegant Quinceanera Dresses 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 3Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 2Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 3
... E-Book Offers Options During National Infertility Awareness ... Blossom Consulting, LLC, a,Chicago-based infertility consultancy with ... their free E-Book, Financing Your Infertility,Treatment, available ... E-Book addresses the financial,aspects of infertility, and ...
... cardio health , , TUESDAY, Nov. 6 (HealthDay News) -- ... practitioners at risk for heart disease in as little ... individuals followed the maintenance phase of the diet -- ... and other markers for heart disease, experts report. ...
... 6, 2007 People who have a mother with Alzheimers disease ... those individuals whose fathers are afflicted, according to a new study ... The study is published in this weeks online edition ... the first to compare brain metabolism among cognitively normal people who ...
... This release is also availabe in Spanish . ... of Granada have devised a new technique to determine the ... was carried out by Dr. Pedro Manuel Garamendi Gonzlez ... Inmaculada Alemn Aguilera . This is of special interest in the ...
... -- Each year, pharmaceutical companies invest millions of dollars to ... because of side effects found only during human clinical trials. ... organ transplants continues to increase. In the past 10 years, ... by a University of Missouri-Columbia physics researcher might present new ...
... seven cities, ... including Largo, Fla., ORLANDO, Fla., Nov. ... techniques supports the widespread use of the American,Heart Association,s new 2005 ... AHA,s Scientific Sessions on November 4 in,Orlando. Lead author, Tom P. ...
Cached Medicine News:Health News:Lotus Blossom Consulting Announces E-Book on Infertility Treatment Financing 2Health News:Atkins Diet Can Raise Heart Risks 2Health News:Atkins Diet Can Raise Heart Risks 3Health News:Atkins Diet Can Raise Heart Risks 4Health News:A maternal link to Alzheimer's disease 2Health News:A maternal link to Alzheimer's disease 3Health News:New technique to determine the age of immigrant minors through ribs and teeth 2Health News:MU research team makes progress toward 'printing' organs 2Health News:MU research team makes progress toward 'printing' organs 3Health News:Study Released at AHA Shows Survival to Hospital Discharge After Cardiac Arrest Doubles With Improved CPR and Impedance Threshold Device 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: